- Capital Cube•9 days ago
Categories: Yahoo Finance Get free summary analysis Nephros, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Nephros, Inc. – Rockwell Medical, Inc., Boston Scientific Corporation, Thermo Fisher Scientific Inc., Baxter International Inc., NxStage Medical, Inc., Mesa Laboratories, Inc. and Danaher Corporation (RMTI-US, BSX-US, TMO-US, BAX-US, ... Read more (Read more...)
- Accesswire•17 days ago
RIVER EDGE, NJ / ACCESSWIRE / August 8, 2016 / Nephros, Inc. (OTCQB: NEPH), (the "Company") a commercial stage medical device company that develops and sells high performance liquid purification ...
- Accesswire•3 months ago
RIVER EDGE, NJ / ACCESSWIRE / June 9, 2016 / Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ...
Nephros, Inc. (NEPH)
OTC BB - OTC BB Delayed Price. Currency in USD
|Day's Range||0.38 - 0.44|
|52wk Range||0.20 - 0.62|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-5.33|
|Avg Vol (3m)||29,445|
|Dividend & Yield||N/A (N/A)|